Consolidated Statement of Cash Flows - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2023
Cash flows from operating activities
Net loss	$ (58,987)	$ (101,346)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	3,643	10,928
Amortization of intangible lease assets and liabilities	(371)	(912)
Amortization of deferred financing costs	(25)	441
Paid-in-kind interest	(1,016)	(3,444)
Realized (gain) loss	(2,846)	718
Net change in unrealized (gain) loss on investments held at fair value	78,238	89,598
Equity in income (losses) of unconsolidated equity method ventures	(1,581)	(23)
Distributions of earnings from unconsolidated ventures	1,692	3,048
Stock-based compensation expense	0	913
Cash paid for life settlement premiums	(3,022)	(3,355)
Changes in operating assets and liabilities, net of effects of acquisitions:
Deferred tax asset	0	1,596
Income tax payable	0	(10,720)
Real estate taxes payable	0	3,135
Operating assets	(3,795)	(4,210)
Operating liabilities	9,459	(4,887)
Net cash provided by (used in) operating activities:	24,551	(18,474)
Cash flows from investing activities
Proceeds from asset redemptions	10,872	0
Distributions from CLO investments	18,100	0
Proceeds from sale of investments	0	29,490
Purchases of investments ($4,034 and $(9,925) with related parties, respectively)	9,925	3,579
Contributions to equity method investments	1,382	0
Additions to consolidated real estate investments	(1,317)	(8,926)
Acquisitions of consolidated real estate investments	(26,500)	0
Proceeds from life settlement policy maturities	0	2,999
Cash from deconsolidation of investment	0	(3,993)
Net cash provided by (used in) investing activities	(10,152)	15,991
Cash flows from financing activities
Proceeds received from notes payable	13,250	20,000
Mortgage payments	(591)	(1,773)
Prime brokerage borrowing	2,567	11,892
Credit facilities payments	(9,500)	(8,999)
Prime brokerage payments	(92)	(12,756)
Deferred financing costs paid	(379)	(771)
Dividends paid to preferred shareholders	(1,155)	(3,465)
Dividends paid to common shareholders	(5,577)	(12,460)
Net cash used in financing activities:	(1,477)	(8,332)
Net decrease in cash, cash equivalents and restricted cash	12,922	(10,815)
Beginning of period	50,776	48,649
End of period	63,698	37,834
Supplemental disclosure of cash flow information
Interest paid	2,722	11,306
Income tax paid	0	13,700
Supplemental Disclosure of Noncash Activities
Non-cash dividend payment	0	4,462
Fair value assets acquired from the contribution of consolidated investments	0	68,500	[1]
Noncash Advisory Fee Payment	$ 0	$ 156

[1] For more information about this transaction, refer to Note 10. Life Settlement Portfolio